Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.45 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | CD81 | P60033 | 1/20 | 0.37 |
| ▸ | FNTA | P49354 | 1/20 | 0.35 |
| ▸ | FNTB | P49356 | 1/20 | 0.35 |
| ▸ | SQLE | Q14534 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 7/20 | 0.34 |
| ▸ | PPARA | Q07869 | 2/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | FBP1 | P09467 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8677618 | 1.00 | EP300 (0.45) | EP300TBXAS1GPR84FFAR1FFAR4 | |
| SCHEMBL743708 | 1.00 | EP300 (0.45) | EP300TBXAS1GPR84FFAR1FFAR4 | |
| SCHEMBL3679830 | 1.00 | EP300 (0.45) | EP300TBXAS1GPR84FFAR1FFAR4 | |
| SCHEMBL21065587 | 1.00 | EP300 (0.45) | EP300TBXAS1GPR84FFAR1FFAR4 | |
| SCHEMBL1686031 | 1.00 | EP300 (0.45) | EP300TBXAS1GPR84FFAR1FFAR4 | |
| SCHEMBL157091 | 1.00 | EP300 (0.45) | EP300TBXAS1GPR84FFAR1FFAR4 | |
| SCHEMBL9069525 | 1.00 | EP300 (0.45) | EP300TBXAS1GPR84FFAR1FFAR4 | |
| SCHEMBL22607803 | 1.00 | EP300 (0.45) | EP300TBXAS1GPR84FFAR1FFAR4 | |
| SCHEMBL21065579 | 1.00 | EP300 (0.45) | EP300TBXAS1GPR84FFAR1FFAR4 | |
| SCHEMBL22607802 | 1.00 | EP300 (0.45) | EP300TBXAS1GPR84FFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3630049-A1 | MICROCAPSULE SYSTEM FOR POLYSENSORY OLFACTORY EFFECTS II | Henkel AG & Co. KGaA (DE) | 2020-04-08 | — | — | EP | disclosed |
| EP-2433617-B1 | Cosmetic composition containing microcapsules | HENKEL AG & CO KGAA (DE) | 2019-05-15 | — | — | EP | disclosed |
| WO-2018215354-A1 | MICROCAPSULE SYSTEM FOR POLYSENSORY OLFACTORY EFFECTS II | HENKEL AG & CO. KGAA (DE) | 2018-11-29 | — | — | WO | disclosed |
| EP-2756066-B1 | AGENT CONTAINING MICROCAPSULES | HENKEL AG & CO KGAA (DE) | 2018-11-14 | — | — | EP | disclosed |
| EP-2544812-B1 | IMPROVED MICROCAPSULES AND PRODUCTION THEREOF | FOLLMANN GMBH & CO KG (DE) | 2018-10-24 | — | — | EP | disclosed |
| EP-2614134-B1 | MICROCAPSULE CONTAINING DETERGENT OR CLEANING AGENT | HENKEL AG & CO KGAA (DE) | 2017-11-08 | — | — | EP | disclosed |
| EP-2756066-A1 | AGENT CONTAINING MICROCAPSULES | Henkel AG&Co. KGAA (DE) | 2014-07-23 | — | — | EP | disclosed |
| EP-2614134-A1 | MICROCAPSULE CONTAINING DETERGENT OR CLEANING AGENT | Henkel AG & Co. KGaA (DE) | 2013-07-17 | — | — | EP | disclosed |
| WO-2013037575-A1 | AGENT CONTAINING MICROCAPSULES | HENKEL AG & CO. KGAA (DE) | 2013-03-21 | — | — | WO | disclosed |
| EP-2544812-A2 | IMPROVED MICROCAPSULES AND PRODUCTION THEREOF | Follmann & Co. Gesellschaft für Chemie-Werkstoffe und -Verfahrenstechnik mbH & Co. KG (DE) | 2013-01-16 | — | — | EP | disclosed |
| US-20120122694-A1 | VERBESSERTE MICROKAPSELN UND IHRE HERSTELLUNG IMPROVED MICROCAPSULES, AND THEIR PRODUCTION THEREOF | Follmann & Co. Gesellschaft fur Chemie-Werkstoffe und Verfahrenstechnik mbH & Co. KG (DE) | 2012-05-17 | — | — | US | disclosed |
| EP-2433617-A2 | Cosmetic composition containing microcapsules | Henkel AG & Co. KGaA (DE) | 2012-03-28 | — | — | EP | disclosed |
| WO-2012032145-A1 | MICROCAPSULE CONTAINING DETERGENT OR CLEANING AGENT | HENKEL AG & CO. KGAA (DE) | 2012-03-15 | — | — | WO | disclosed |
| EP-2406002-A2 | IMPROVED MICROCAPSULES, AND PRODUCTION THEREOF | Follmann & Co. Gesellschaft für Chemie-Werkstoffe und -Verfahrenstechnik mbH & Co. KG (DE) | 2012-01-18 | — | — | EP | disclosed |
| WO-2011110368-A2 | IMPROVED MICROCAPSULES AND PRODUCTION THEREOF | FOLLMANN & CO. GESELLSCHAFT FÜR CHEMIE-WERKSTOFFE UND -VERFAHRENSTECHNIK MBH & CO. KG (DE) | 2011-09-15 | — | — | WO | disclosed |
| EP-2364773-A1 | Improved microcapsules and their manufacture | Follmann & Co. Gesellschaft für Chemie-Werkstoffe und -Verfahrenstechnik mbH & Co. KG (DE) | 2011-09-14 | — | — | EP | disclosed |
| WO-2010102830-A2 | IMPROVED MICROCAPSULES, AND PRODUCTION THEREOF | FOLLMANN & CO. GESELLSCHAFT FÜR CHEMIE-WERKSTOFFE UND VERFAHRENSTECHNIK MBH & CO. KG (DE) | 2010-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122694-A1 | VERBESSERTE MICROKAPSELN UND IHRE HERSTELLUNG IMPROVED MICROCAPSULES, AND THEIR PRODUCTION THEREOF | VIM, ADH5, DCXR | EP300 112/4885TBXAS1 3703/4885GPR84 3929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.